Skip to main content

Drug Interactions between chikungunya vaccine, live (cvx 317) and diphtheria antitoxin

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Major

diphtheria antitoxin chikungunya vaccine, live (cvx 317)

Applies to: diphtheria antitoxin and chikungunya vaccine, live (cvx 317)

Diphtheria antitoxin may interfere with your body's immune response to chikungunya vaccine, live (cvx 317). If you have been treated with diphtheria antitoxin or received a blood product, your doctor may suggest you wait a certain period of time before being vaccinated with chikungunya vaccine, live (cvx 317). If you were vaccinated with chikungunya vaccine, live (cvx 317) shortly before or after diphtheria antitoxin, revaccination and/or laboratory testing for vaccine immunity may be necessary. The immunizing doctor should be informed of recent therapy with diphtheria antitoxin or any blood product so that appropriate measures and/or precautions can be taken. It is important to tell the doctor about all other medications being used, including vitamins and herbs. Do not stop using any medications without first talking to the doctor.

Switch to professional interaction data

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer